Please read abstract in the article.The EMPIRE-1 trial received funding from the National Institutes of Health/National Cancer Institute (R01 CA16918), Blue Earth Diagnostics, Ltd., and the Winship Cancer Institute of Emory University.http://journals.lww.com/nuclearmed/pages/default.aspx2023-12-14Nuclear Medicin